|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cavalcanti IDL and Soares JCS:
Conventional Cancer Treatment. In: Advances in Cancer Treatment.
Springer, Cham, pp29-56, 2021.
|
|
3
|
Hulya E, Burcu C, Birol O, Sibel OO, Erdem
C and Ozkan K: Evaluation of complementary and alternative medicine
use in cancer patients: A survey study in Turkey. AIMED. 12:99–103.
2025.
|
|
4
|
Keene MR, Heslop IM, Sabesan SS and Glass
BD: Complementary and alternative medicine use in cancer: A
systematic review. Complement Ther Clin Pract. 35:33–47.
2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Knecht K, Kinder D and Stockert A:
Biologically-Based complementary and alternative medicine (CAM) use
in cancer patients: The good, the bad, the misunderstood. Front
Nutr. 6(196)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Atanasov AG, Zotchev SB and Dirsch VM:
International Natural Product Sciences Taskforce. Supuran CT:
Natural products in drug discovery: advances and opportunities. Nat
Rev Drug Discov. 20:200–216. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Basmadjian C, Zhao Q, Bentouhami E, Ajehal
A, Nebigil CG, Johnson RA, Serova M, de Gramont A, Faivre S,
Raymond E and Désaubry LG: Cancer wars: Natural products strike
back. Front Chem. 2(20)2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pattanayak S: Plants in healthcare: Past,
present and future. Explor Anim Med Res. 11:140–144. 2021.
|
|
9
|
Kelly K: History of Medicine. Oxford
University Press, New York, 2009.
|
|
10
|
Petrovska BB: Historical review of
medicinal plants' usage. Pharmacogn Rev. 6:1–5. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang YH, Mao JW and Tan XL: Research
progress on the source, production, and anti-cancer mechanisms of
paclitaxel. Chin J Nat Med. 18:890–897. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhu L and Chen L: Progress in research on
paclitaxel and tumour immunotherapy. Cell Mol Biol Lett.
24(40)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Keller-Juslen C, Kuhn M, Staehelin H and
Von Wartburg A: Synthesis and antimitotic activity of glycosidic
lignan derivatives related to podophyllotoxin. J Med Chem.
14:936–940. 1971.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Reyhanoglu G and Tadi P: Etoposide.
StatPearls Publishing, Treasure Island, FL, 2025.
|
|
15
|
Noble RL: The discovery of the vinca
alkaloids-chemotherapeutic agents against cancer. Biochem Cell
Biol. 68:1344–1351. 1990.PubMed/NCBI
|
|
16
|
Škubník J, Pavlíčková VS, Ruml T and
Rimpelová S: Vincristine in combination therapy of cancer: Emerging
trends in clinics. Biology (Basel). 10(849)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Harris S: Dodonaea viscosa var.
angustifolia. Karoo Desert National Botanical Garden. In:
PlantZAfrica. Available from: https://pza.sanbi.org/dodonaea-viscosa-var-angustifolia,
2012.
|
|
18
|
Ngabaza T, Johnson MM, Moeno S and Patel
M: Identification of
5,6,8-Trihydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one
with antimicrobial activity from Dodonaea viscosa var.
angustifolia. S Afr J Bot. 112:48–53. 2017.
|
|
19
|
Al-Snafi AE: A review on Dodonaea viscosa:
A potential medicinal plant. IOSR J Pharm. 7:10–21. 2017.
|
|
20
|
Hossain MA: Biological and phytochemicals
review of Omani medicinal plant Dodonaea viscosa. J King Saud Univ
Sci. 31:1089–1094. 2019.
|
|
21
|
Saranya K and Divyabharathi U: Gas
chromatography and mass spectroscopic analysis of phyto-compounds
in Dodonaea viscosa leaf extract. Pramana Res J. 9:26–35.
2019.https://www.pramanaresearch.org/gallery/prj-p1302.pdf.
|
|
22
|
Hoffman M, Marx J, Kaigongi MM, Masondo
NA, Lukhoba CW, Yenesew A and Makunga NP: Reflecting on the
interesting phytopharmacology of the cosmopolitan Dodonaea genus:
Past, present and future. Phytochem Rev: Aug 1, 2025 (Epub ahead of
print).
|
|
23
|
Mossa GD and Al-Shawi AA: Induction of
apoptosis through S-phase in human breast cancer MDA-MB231 cells by
ethanolic extract of Dodonaea viscosa L. - an Iraqi medicine plant.
J Basrah Res. 41:119–128. 2015.
|
|
24
|
Ramkumar R, Periyasamy SK, Venkatraman BR
and Sekar KG: In-vitro anti-cancer and anti-inflammatory screening
of dodonaea viscosa. J Pharm Res Int. 33:186–192. 2021.
|
|
25
|
Herrera-Calderon O, Rahman MH, Pena-Rojas
G and Andia-Ayme V: (2020) Dodonaea viscosa Jacq: A medicinal plant
with cytotoxic effect on colon cancer cell line (HT-29). J Pure
Appl Microbiol. 14:1927–1934. 2020.
|
|
26
|
Herrera-Calderon O, Herrera-Ramírez A,
Cardona-G W, Melgar-Merino EJ, Chávez H, Pari-Olarte JB,
Loyola-Gonzales E, Kong-Chirinos JF, Almeida-Galindo JS, Peña-Rojas
G and Andía-Ayme V: Dodonaea viscosa Jacq. induces cytotoxicity,
antiproliferative activity, and cell death in colorectal cancer
cells via regulation of caspase 3 and p53. Front Pharmacol.
14(1197569)2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Malik MN, Haq I, Fatima H, Ahmad M, Naz I,
Mirza B and Kanwal N: Bioprospecting Dodonaea viscosa Jacq.; a
traditional medicinal plant for antioxidant, cytotoxic,
antidiabetic and antimicrobial potential. Arab J Chem.
15(103688)2022.
|
|
28
|
Cao S, Brodie P, Callmander M,
Randrianaivo R, Razafitsalama J, Rakotobe E, Rasamison VE, TenDyke
K, Shen Y, Suh EM and Kingston DG: Antiproliferative triterpenoid
saponins of Dodonaea viscosa from the Madagascar dry forest. J Nat
Prod. 72:1705–1707. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Priya VT, Balasubramanian N, Shanmugaiah
V, Sathishkumar P, Kannan ND, Karunakaran C, Alfarhan A and
Antonisamy P: Partially purified lead molecules from Dodonaea
viscosa and their antimicrobial efficacy against infectious human
pathogens. J Infect Public Health. 14:1822–1830. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Saferdien A: Anti-cancer effects of
aqueous extracts of Dodonaea viscosa on Burkitt lymphoma. PhD
dissertation, University of Cape Town, 2023. http://hdl.handle.net/11427/42528.
|
|
31
|
Jin C, Wang K, Oppong-Gyebi A and Hu J:
Application of nanotechnology in cancer diagnosis and therapy-A
mini-review. Int J Med Sci. 17:2964–2973. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mosleh-Shirazi S, Abbasi M, Moaddeli MR,
Vaez A, Shafiee M, Kasaee SR, Amani AM and Hatam S: Nanotechnology
advances in the detection and treatment of cancer: An overview.
Nanotheranostics. 6:400–423. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Gomes HIO, Martins CSM and Prior JAV:
Silver nanoparticles as carriers of anticancer drugs for efficient
target treatment of cancer cells. Nanomaterials (Basel).
11(964)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Al-Musawi ZFH and Al-Saadi NHM: Antitumor
activities of biosynthesized silver nanoparticles using Dodonaea
viscosa (L.) leaves extract. Basrah J Agri Sci. 34:42–59. 2021.
|
|
35
|
Anandan M, Poorani G, Boomi P, Varunkumar
K, Anand K, Chuturgoon AA, Saravanan M and Gurumallesh Prabu H:
Green synthesis of anisotropic silver nanoparticles from the
aqueous leaf extract of Dodonaea viscosa with their antibacterial
and anticancer activities. Process Biochem. 80:80–88. 2019.
|
|
36
|
Alghamdi MD, Nazreen S, Ali NM and Amna T:
ZnO Nanocomposites of Juniperus procera and Dodonaea viscosa
extracts as antiproliferative and antimicrobial agents.
Nanomaterials (Basel). 12(664)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Alasmari A: Hepatoprotective activity of
Dodonaea viscosa leaf extract nanoparticles against
N-nitrosodiethylamine induced tumor initiation in rat liver:
Modulation of apoptosis and signaling pathways. J Environ Biol.
43:177–187. 2022.
|
|
38
|
Sznarkowska A, Kostecka A, Meller K and
Bielawski KP: Inhibition of cancer antioxidant defense by natural
compounds. Oncotarget. 8:15996–16016. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ali H, Kabir N, Muhammad A, Shah MR,
Musharraf SG, Iqbal N and Nadeem S: Hautriwaic acid as one of the
hepatoprotective constituents of Dodonaea viscosa. Phytomedicine.
21:131–140. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Auta R, Waziri P, Oweh OT, Wayah S,
Tyoapine D, Bobai M, Solomon B and Onyemaobi U: Antibacterial,
anticancer and antioxidant properties of the stem and leaf extract
of Dodonaea viscosa. Sci World J. 20:331–335. 2025.
|
|
41
|
Ramkumar R and Periyasamy SK:
Anti-inflammatory activity of Dodonaea viscosa leaves. IJRAR.
6:223–225. 2019.
|
|
42
|
Salinas-Sánchez DO, Herrera-Ruiz M, Pérez
S, Jimenez-Ferre E and Zamilpa A: Anti-inflammatory activity of
hautriwaic acid isolated from Dodonaea viscosa leaves. Molecules.
17:4292–4299. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Khan AZ, Mohammad A, Iqbal Z, Anis I, Shah
MR, Nadeem S, Rabnawaz M, Shahidullah A, Khan H and Khan I:
Molecular docking of viscosine as a new lipoxygenase inhibitor
isolated from Dodonaea viscosa. Bangladesh J Pharmacol. 8:36–39.
2013.
|
|
44
|
Majeed ZH, Hasan SA and Ismail RM:
Evaluate the benefit effects of Dodonaea viscosa in kidney of
infected rats with Staphylococcus aureus. J Pharm Negat Results.
13:291–294. 2022.
|
|
45
|
Hamed Al Bimani BM and Hossain MA: A new
antimicrobial compound from the leaves of Dodonaea viscosa for
infectious diseases. Bioact Mater. 5:602–610. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Naidoo R, Patel M, Gulube Z and Fenyvesi
I: Inhibitory activity of Dodonaea viscosa var. angustifolia
extract against Streptococcus mutans and its biofilm. J
Ethnopharmacol. 144:171–174. 2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Tong ZW, Gul H, Awais M, Saddick S, Khan
FS, Gulfraz M, Afzal U, Nazir K, Malik MY, Khan SU and Khan MI:
Determination of in vivo biological activities of Dodonaea viscosa
flowers against CCL4 toxicity in albino mice with bioactive
compound detection. Sci Rep. 11(13336)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Patel M and Coogan MM: Antifungal activity
of the plant Dodonaea viscosa var. angustifolia on Candida albicans
from HIV-infected patients. J Ethnopharmacol. 118:173–176.
2008.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Patel M, Srivastava V and Ahmad A:
Dodonaea viscosa var angustifolia derived 5, 6, 8-trihydroxy-7, 4'
dimethoxy flavone inhibits ergosterol synthesis and the production
of hyphae and biofilm in Candida albicans. J Ethnopharmacol.
259(112965)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bizuayehu HM, Ahmed KY, Kibret GD, Dadi
AF, Belachew SA, Bagade T, Tegegne TK, Venchiarutti RL, Kibret KT,
Hailegebireal AH, et al: Global disparities of cancer and its
projected Burden in 2050. JAMA Netw Open.
7(e2443198)2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Rashed K, Meng TL, Lin-Tao Z and Yong-Tang
Z: Dodonaea viscosa (L.) extracts as anti human immunodeficiency
virus type-1 (HIV-1) agents and phytoconstituents. Peak J of
Medicinal Plant Research. 1:19–25. 2013.
|
|
52
|
Shaheen M, Borsanyiova M, Mostafa S,
Chawla-Sarkar M, Bopegamage S and El-esnawy N: In vitro effect of
Dodonaea viscosa extracts on the replication of coxackievirus B3
(Nancy) and rotavirus (SA-11). JMAA. 1:47–54. 2015.
|
|
53
|
Akhtar MS, Ahmed M, Gulzar K and Adnan H:
Hypoglycemic activity of Dodonaea viscosa leaves in normal and
alloxan-induced diabetic rabbits. Diabetologia Croatica. 40:71–79.
2011.
|
|
54
|
Muthukumran P, Hazeena Begumand V and
Kalaiarasan P: Anti-diabetic activity of Dodonaea viscosa (L) leaf
extracts. Int J PharmTech Res. 3:136–139. 2011.
|
|
55
|
Sandhya Rani M, Venkatesh P, Pippalla RS
and Mohan GK: Biochemical and histological study of traditional
plant: Dodonaea viscosa Linn extracts in diabetic rats. J
Phytopharmacol. 2:13–21. 2013.
|
|
56
|
Alanazi AZ, Al-Rejaie SS, Ahmed MM,
Alhazzani K, Alhosaini K, As Sobeai HM, Alsanea S, Alam P,
Almarfadi OM, Alqahtani AS, et al: Protective role of Dodonaea
viscosa extract against streptozotocin-induced hepatotoxicity and
nephrotoxicity in rats. Saudi Pharm J. 31(101669)2023.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Subramanian S, Duraipandian C, Alsayari A,
Ramachawolran G, Wong LS, Sekar M, Gan SH, Subramaniyan V,
Seethalakshmi S, Jeyabalan S, et al: Wound healing properties of a
new formulated flavonoid-rich fraction from Dodonaea viscosa Jacq.
leaves extract. Front Pharmacol. 14(1096905)2023.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Nayeem N, Asdaq SMB, Alamri AS, Alsanie
WF, Alhomrani M, Mohzari Y, Alrashed AA, Alotaibi N, aalhathal AS,
Alharbi MA, et al: Wound healing potential of Dodonaea viscosa
extract formulation in experimental animals. J King Saud Univ Sci.
33(101476)2021.
|
|
59
|
Arun M and Asha VV: Gastroprotective
effect of Dodonaea viscosa on various experimental ulcer models. J
Ethnopharmacol. 118:460–465. 2008.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Rajamanickam V, Rajasekaran A,
Anandarajagopal K, Sridharan D, Selvakumar K and Benjamin SR:
Anti-diarrheal activity of Dodonaea viscosa root extracts. Int J
Pharma Bio Sci. 1:182–185. 2010.
|
